Toronto, Ontario--(Newsfile Corp. - August 21, 2025) - NuGen Medical Devices Inc. (NGMD:CA) ("NuGen" or the "Company"), a leader in needle-free subcutaneous drug-delivery technology, is pleased to ...

Single-use and reusable needle-free injection devices will be designed for precise self-administration and home use. PharmaJet injector pens are intended for needle-free subcutaneous delivery of a ...

The MarketWatch News Department was not involved in the creation of this content. -- PharmaJet's intramuscular (IM) Needle-free Injection System - Stratis(R) - was used to deliver Scancell's iSCIB1+ ...

CHICAGO--(BUSINESS WIRE)--Sol-Millennium® Medical Group, manufacturer of medical devices, including syringes for medication delivery and testing, is proud to announce the launch of InsuJet™ ...

CAMBRIDGE, MA, UNITED STATES, October 16, 2025 /EINPresswire.com/ -- Portal Instruments and Regeneron Publish Study Demonstrating PRIME ® Needle-Free Drug Delivery ...

The PharmaJet Needle-free Delivery System has shown effective uptake of the SCIB1 DNA vaccine in addition to offering speed, convenience, and enhanced patient experience. PharmaJet is eligible to ...

For a century and a half, the sharp end of a needle has been the price of admission for modern medicine. Generations of children and parents have been conditioned to […] ...

(A) Dynamics of the electrically induced microbubble, showing the formation, expansion, and shrinking of the microbubble and the shock wave and microjet from the microbubble. (B) Mechanism of the ...

FlowBeams' needle-free injection technology could prove to be a watershed moment in healthcare and aesthetic dermatology Development of the world’s first affordable laser-based, needle-free injection ...

Vaccinating children is always a challenging task, especially when it involves needles, as they can make the process more unpleasant. But when a toddler somewhere in eastern India slept throughout her ...

PharmaJet’s intramuscular (IM) Needle-free Injection System - Stratis® - was used to deliver Scancell’s iSCIB1+ DNA immunotherapy in combination with immune checkpoint inhibitors in the SCOPE Phase 2 ...